In addition, high levels of SIRT5 predicted shorter PFS and were positively associated with clinicopathologic characteristics of ovarian cancer, such as advanced FIGO stage and lymph node metastasis, but were negatively correlated with differentiation. This evidence concerns the gene SIRT5 and metastatic malignant neoplasm in the lymph nodes.